Hepatitis Monthly

Published by: Kowsar

Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction

Gian Paolo Caviglia 1 , * and Rinaldo Pellicano 2
Authors Information
1 Department of Medical Sciences, University of Turin, Turin, Italy
2 Department of Gastroenterology, Citta della Salute e della Scienza, Molinette Hospital, Turin, Italy
Article information
  • Hepatitis Monthly: August 01, 2015, 15 (8); e30853
  • Published Online: August 17, 2015
  • Article Type: Letter
  • Received: June 17, 2015
  • Accepted: July 4, 2015
  • DOI: 10.5812/hepatmon.30853

To Cite: Caviglia G P, Pellicano R. Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction, Hepat Mon. 2015 ;15(8):e30853. doi: 10.5812/hepatmon.30853.

Copyright © 2015, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnote
References
  • 1. Yang ZH, Yang SX, Qin CZ, Chen YX. Clinical values of elevated serum cytokeratin-18 levels in hepatitis: a meta-analysis. Hepat Mon. 2015; 15(5)[DOI][PubMed]
  • 2. Caviglia GP, Ciancio A, Rosso C, Abate ML, Olivero A, Pellicano R, et al. Non-invasive methods for the assessment of hepatic fibrosis: transient elastography, hyaluronic acid, 13C-aminopyrine breath test and cytokeratin 18 fragment. Ann Hepatol. 2013; 13(1): 91-7[PubMed]
  • 3. Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, et al. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Gut. 2008; 57(4): 500-6[DOI][PubMed]
  • 4. Eguchi A, Wree A, Feldstein AE. Biomarkers of liver cell death. J Hepatol. 2014; 60(5): 1063-74[DOI][PubMed]
  • 5. Cusi K, Chang Z, Harrison S, Lomonaco R, Bril F, Orsak B, et al. Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol. 2014; 60(1): 167-74[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments